Lafayette Father Becomes First in Colorado to Receive Newly Approved Pancreatic Cancer Drug

A Lafayette dad with stage 4 pancreatic cancer is the first patient in Colorado to receive the newly approved targeted therapy Zenocutuzumab, showing a promising response.